WuXi Biologics And WuXi AppTec Plan $2.8 Billion Investment In Singapore Facilities
Frontera Therapeutics completed a $160 million Series B funding to support its AAV programs.
Source: seekingalpha.com
Fast, Ad-Free News Updates
Stay updated with breaking news from China Accelerator. Real-time updates on events, politics, business and more.